Perspective Therapeutics Inc
For the period ended Apr 18, 2024. Filed Apr 18, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Apr 18, 2024 · Filed Apr 18, 2024
Contents
Interest of Certain Persons
Each of our directors and executive officers is eligible to participate in the Plan.
You may vote either “FOR,” “AGAINST,” or “ABSTAIN” on Proposal 4. The vote required to approve Proposal 4 is governed by Delaware law and the Company’s bylaws and is the affirmative vote of a majority in voting power of shares of common stock present in person or represented by proxy and entitled to vote thereon. As a result, abstentions will be considered in determining whether a quorum is present and the number of votes required to obtain the necessary majority vote, and therefore will have the same effect as voting against Proposal 4.
The Board unanimously recommends that the stockholders vote “FOR”Proposal 4 to approve the Company’s Third Amended and Restated 2020 Equity Incentive Plan.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.